Effect of Breathing Oxygen-Enriched Air on Exercise Performance in Patients With Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction: A Randomized, Placebo-Controlled, Crossover Trial

Julian Müller, Mona Lichtblau, Stéphanie Saxer, Luigi-Riccardo Calendo, Arcangelo F Carta, Simon R Schneider, Charlotte Berlier, Michael Furian, Konrad E Bloch, Esther I Schwarz, Silvia Ulrich, Julian Müller, Mona Lichtblau, Stéphanie Saxer, Luigi-Riccardo Calendo, Arcangelo F Carta, Simon R Schneider, Charlotte Berlier, Michael Furian, Konrad E Bloch, Esther I Schwarz, Silvia Ulrich

Abstract

Objective: To evaluate the effects of breathing oxygen-enriched air (oxygen) on exercise performance in patients with pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF). Methods: Ten patients with PH-HFpEF (five women, age 60 ± 9 y, mPAP 37 ± 14 mmHg, PAWP 18 ± 2 mmHg, PVR 3 ± 3 WU, resting SpO2 98 ± 2%) performed two-cycle incremental exercise tests (IET) and two constant-work-rate exercise test (CWRET) at 75% maximal work-rate (W max), each with ambient air (FiO2 0.21) and oxygen (FiO2 0.5) in a randomized, single-blinded, cross-over design. The main outcomes were the change in W max (IET) and cycling time (CWRET) with oxygen vs. air. Blood gases at rest and end-exercise, dyspnea by Borg CR10 score at end-exercise; continuous SpO2, minute ventilation (V'E), carbon dioxide output (V'CO2), and cerebral and quadricep muscle tissue oxygenation (CTO and QMTO) were measured. Results: With oxygen vs. air, W max (IET) increased from 94 ± 36 to 99 ± 36 W, mean difference (95% CI) 5.4 (0.9-9.8) W, p = 0.025, and cycling time (CWRET) from 532 ± 203 to 680 ± 76 s, +148 (31.8-264) s, p = 0.018. At end-exercise with oxygen, Borg dyspnea score and V'E/V'CO2 were lower, whereas PaO2 and end-tidal PaCO2 were higher. Other parameters were unchanged. Conclusion: Patients with PH-HFpEF not revealing resting hypoxemia significantly improved their exercise performance while breathing oxygen-enriched air along with less subjective dyspnea sensation, a better blood oxygenation, and an enhanced ventilatory efficiency. Future studies should investigate whether prolonged training with supplemental oxygen would increase the training effect and, potentially, daily activity for PH-HFpEF patients. Clinical Trial Registration: [clinicaltrials.gov], identifier [NCT04157660].

Keywords: cardiopulmonary exercise test; exercise; external cycling work; heart failure with preserved ejection fraction; oxygen therapy; pulmonary hypertension.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2021 Müller, Lichtblau, Saxer, Calendo, Carta, Schneider, Berlier, Furian, Bloch, Schwarz and Ulrich.

Figures

Figure 1
Figure 1
Patient flow of the study. N = Number of participants.
Figure 2
Figure 2
Improvements of the primary outcomes with oxygen. Changes of maximal work-rate [Wmax (W)] at the incremental exercise test (left, purple) and mean changes of maximal cycling time [t (s)] of the constant work-rate exercise test (right, green) with oxygen-enriched vs. ambient air are shown as mean ± standard error of mean (SEM). IET, incremental exercise test; CWRET, constant work-rate exercise test.
Figure 3
Figure 3
Physiological changes during the incremental exercise test. Physiological changes of the incremental exercise test comparing tests with air (blue) vs. oxygen-enriched air (red) by computing means over each 10% fraction of maximal exercise duration individually achieved with ambient air, i.e., 1–10%, 11–20%, etc., up to 91–100% of total exercise duration and end-exercise defined as the mean over the final 30 s of the test. HR, heart rate; SpO2, arterial oxygen saturation; QMTO, quadriceps muscle tissue oxygenation; CTO, cerebral tissue oxygenation; V'E, minute ventilation; V'CO2, carbon dioxide output.
Figure 4
Figure 4
Cycling energy delivery during incremental vs. constant work-rate exercise test (IET vs. CWRET). (A) Graphical representation of the constant work-rate exercise test (CWRET, blue) with air for a mean cycling time of 418 s and a mean work-rate of 70W. (B) Graphical representation of the incremental exercise test (IET, red) with air for a mean cycling time of 361 s and a mean work-rate of 94W, starting with 20W. (C) Graphical representation of the mean delivered external work of the patients, calculated with the integral of the work-rate over cycling time, comparing both tests [CWRET (blue); IET (red)] with air. The curves represent the estimated progress with time for both tests. (D) Graphical representation of the mean delivered external work of the patients, calculated with the integral of the work-rate over cycling time, comparing both tests [CWRET (blue); IET (red)] with oxygen. The curves represent the estimated progress with time for both tests. ∫ W dt = external work (J).

References

    1. Del Buono MG, Arena R, Borlaug BA, Carbone S, Canada JM, Kirkman DL, et al. . Exercise intolerance in patients with heart failure: JACC state-of-the-art review. J Am Coll Cardiol. (2019) 73:2209–25. 10.1016/j.jacc.2019.01.072
    1. Rosenkranz S, Gibbs JS, Wachter R, De Marco T, Vonk-Noordegraaf A, Vachiery JL. Left ventricular heart failure and pulmonary hypertension. Eur Heart J. (2016) 37:942–54. 10.1093/eurheartj/ehv512
    1. Holland DJ, Kumbhani DJ, Ahmed SH, Marwick TH. Effects of treatment on exercise tolerance, cardiac function, and mortality in heart failure with preserved ejection fraction. A meta-analysis. J Am Coll Cardiol. (2011) 57:1676–86. 10.1016/j.jacc.2010.10.057
    1. Taylor RS, Walker S, Smart NA, Piepoli MF, Warren FC, Ciani O, et al. . Impact of exercise rehabilitation on exercise capacity and quality-of-life in heart failure: individual participant meta-analysis. J Am Coll Cardiol. (2019) 73:1430–43. 10.1016/j.jacc.2018.12.072
    1. Kumar AA, Kelly DP, Chirinos JA. Mitochondrial dysfunction in heart failure with preserved ejection fraction. Circulation. (2019) 139:1435–50. 10.1161/CIRCULATIONAHA.118.036259
    1. Houstis NE, Eisman AS, Pappagianopoulos PP, Wooster L, Bailey CS, Wagner PD, et al. . Exercise intolerance in heart failure with preserved ejection fraction: diagnosing and ranking its causes using personalized O2 pathway analysis. Circulation. (2018) 137:148–61. 10.1161/CIRCULATIONAHA.117.029058
    1. Ulrich S, Hasler ED, Muller-Mottet S, Keusch S, Furian M, Latshang TD, et al. . Mechanisms of improved exercise performance under hyperoxia. Respiration. (2017) 93:90–8. 10.1159/000453620
    1. Ulrich S, Hasler ED, Saxer S, Furian M, Muller-Mottet S, Keusch S, et al. . Effect of breathing oxygen-enriched air on exercise performance in patients with precapillary pulmonary hypertension: randomized, sham-controlled cross-over trial. Eur Heart J. (2017) 38:1159–68. 10.1093/eurheartj/ehx099
    1. Hasler ED, Saxer S, Schneider SR, Furian M, Lichtblau M, Schwarz EI, et al. . Effect of breathing oxygen-enriched air on exercise performance in patients with chronic obstructive pulmonary disease: randomized, placebo-controlled, cross-over trial. Respiration. (2020) 99:213–24. 10.1159/000505819
    1. Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. . 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. (2016) 37:67–119. 10.1093/eurheartj/ehv317
    1. World Medical A . World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. (2013) 310:2191–4. 10.1001/jama.2013.281053
    1. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. . 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Rev Esp Cardiol.(2016) 69:1167. 10.1002/ejhf.592
    1. Ulrich S, Schneider SR, Bloch KE. Effect of hypoxia and hyperoxia on exercise performance in healthy individuals and in patients with pulmonary hypertension: a systematic review. J Appl Physiol (1985). (2017) 123:1657–70. 10.1152/japplphysiol.00186.2017
    1. Subudhi AW, Dimmen AC, Roach RC. Effects of acute hypoxia on cerebral and muscle oxygenation during incremental exercise. J Appl Physiol (1985). (2007) 103:177–83. 10.1152/japplphysiol.01460.2006
    1. Ulrich S, Nussbaumer-Ochsner Y, Vasic I, Hasler E, Latshang TD, Kohler M, et al. . Cerebral oxygenation in patients with OSA: effects of hypoxia at altitude and impact of acetazolamide. Chest. (2014) 146:299–308. 10.1378/chest.13-2967
    1. Muller-Mottet S, Hildenbrand FF, Keusch S, Hasler E, Maggiorini M, Speich R, et al. . Effects of exercise and vasodilators on cerebral tissue oxygenation in pulmonary hypertension. Lung. (2014) 193:113–20. 10.1007/s00408-014-9667-5
    1. Ferreira EV, Ota-Arakaki JS, Ramos RP, Barbosa PB, Almeida M, Treptow EC, et al. . Optimizing the evaluation of excess exercise ventilation for prognosis assessment in pulmonary arterial hypertension. Eur J Prev Cardiol. (2014) 21:1409–19. 10.1177/2047487313494293
    1. Glaser S, Ittermann T, Schaper C, Obst A, Dorr M, Spielhagen T, et al. . [The study of health in Pomerania (SHIP) reference values for cardiopulmonary exercise testing]. Pneumologie. (2013) 67:58–63. 10.1055/s-0032-1325951
    1. Casaburi R. Factors determining constant work rate exercise tolerance in COPD and their role in dictating the minimal clinically important difference in response to interventions. COPD. (2005) 2:131–6. 10.1081/COPD-200050576
    1. Puhan MA, Chandra D, Mosenifar Z, Ries A, Make B, Hansel NN, et al. . The minimal important difference of exercise tests in severe COPD. Eur Respir J. (2011) 37:784–90. 10.1183/09031936.00063810
    1. Sperlich B, Zinner C, Hauser A, Holmberg HC, Wegrzyk J. The impact of hyperoxia on human performance and recovery. Sports Med. (2017) 47:429–38. 10.1007/s40279-016-0590-1
    1. Noakes TD, Peltonen JE, Rusko HK. Evidence that a central governor regulates exercise performance during acute hypoxia and hyperoxia. J Exp Biol. (2001) 204:3225–34. 10.1242/jeb.204.18.3225
    1. Yan Z, Spaulding HR. Extracellular superoxide dismutase, a molecular transducer of health benefits of exercise. Redox Biol. (2020) 32:101508. 10.1016/j.redox.2020.101508
    1. Aad G, Abajyan T, Abbott B, Abdallah J, Abdel Khalek S, Abdelalim AA, et al. . Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett. (2013) 110:182302. 10.1103/PhysRevLett.110.182302
    1. Prieur F, Benoit H, Busso T, Castells J, Geyssant A, Denis C. Effects of moderate hyperoxia on oxygen consumption during submaximal and maximal exercise. Eur J Appl Physiol. (20020 88:235–42. 10.1007/s00421-002-0707-0
    1. Nielsen HB, Boushel R, Madsen P, Secher NH. Cerebral desaturation during exercise reversed by O2 supplementation. Am J Physiol. (1999) 277:H1045–52. 10.1152/ajpheart.1999.277.3.H1045
    1. Hesse B, Kanstrup IL, Christensen NJ, Ingemann-Hansen T, Hansen JF, Halkjaer-Kristensen J, et al. . Reduced norepinephrine response to dynamic exercise in human subjects during O2 breathing. J Appl Physiol Respir Environ Exerc Physiol. (1981) 51:176–8. 10.1152/jappl.1981.51.1.176
    1. Howley ET, Cox RH, Welch HG, Adams RP. Effect of hyperoxia on metabolic and catecholamine responses to prolonged exercise. J Appl Physiol Respir Environ Exerc Physiol. (1983) 54:59–63. 10.1152/jappl.1983.54.1.59
    1. Sarma S, Levine BD. Soothing the sleeping giant: improving skeletal muscle oxygen kinetics and exercise intolerance in HFpEF. J Appl Physiol (1985). (2015) 119:734–8. 10.1152/japplphysiol.01127.2014
    1. Haykowsky MJ, Brubaker PH, John JM, Stewart KP, Morgan TM, Kitzman DW. Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. J Am Coll Cardiol. (2011) 58:265–74. 10.1016/j.jacc.2011.02.055
    1. Dobre D, van Veldhuisen DJ, DeJongste MJ, Lucas C, Cleuren G, Sanderman R, et al. . Prescription of beta-blockers in patients with advanced heart failure and preserved left ventricular ejection fraction. Clinical implications and survival. Eur J Heart Fail. (2007) 9:280–6. 10.1016/j.ejheart.2006.07.008
    1. Bernardi L, Porta C, Spicuzza L, Bellwon J, Spadacini G, Frey AW, et al. . Slow breathing increases arterial baroreflex sensitivity in patients with chronic heart failure. Circulation. (2002) 105:143–5. 10.1161/hc0202.103311
    1. Plet J, Pedersen PK, Jensen FB, Hansen JK. Increased working capacity with hyperoxia in humans. Eur J Appl Physiol Occup Physiol. (1992) 65:171–7. 10.1007/BF00705076
    1. Amann M, Eldridge MW, Lovering AT, Stickland MK, Pegelow DF, Dempsey JA. Arterial oxygenation influences central motor output and exercise performance via effects on peripheral locomotor muscle fatigue in humans. J Physiol. (2006) 575:937–52. 10.1113/jphysiol.2006.113936
    1. Linossier MT, Dormois D, Arsac L, Denis C, Gay JP, Geyssant A, et al. . Effect of hyperoxia on aerobic and anaerobic performances and muscle metabolism during maximal cycling exercise. Acta Physiol Scand. (2000) 168:403–11. 10.1046/j.1365-201x.2000.00648.x
    1. Oussaidene K, Prieur F, Bougault V, Borel B, Matran R, Mucci P. Cerebral oxygenation during hyperoxia-induced increase in exercise tolerance for untrained men. Eur J Appl Physiol. (2013) 113:2047–56. 10.1007/s00421-013-2637-4
    1. Wilkerson DP, Berger NJ, Jones AM. Influence of hyperoxia on pulmonary O2 uptake kinetics following the onset of exercise in humans. Respir Physiol Neurobiol. (2006) 153:92–106. 10.1016/j.resp.2005.09.006

Source: PubMed

3
Iratkozz fel